JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
Recruiting · NCT06954467 · Registry updated 2025-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2025-07-02 | NCT06954467 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Junshi Bioscience Co., Ltd. | 42 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Hunan Cancer Hospital | Changsha | China | 41 |
| Peking Union Medical College Hospital | Beijing | China | 19 |
| Ruijin Hospital, Shanghai Jiao Tong University School of Medicine City:Shanghai | Shanghai | China | 1 |
| Shanghai East Hospital,School of Medicine, Tongji University | Shanghai | China | 1 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 109 |
| The First Affiliated Hospital of USTC | Hefei | China | 1 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 6 |
| The first Hospital of China Medical University | Shenyang | China | 3 |
| Zhongshan Hospital affiliated to Fudan University | Shanghai | China | 2 |